Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Myriad Genetics, Inc. - SWOT Analysis' returned 98 results - Page 1 of 5  FEATURED RESULTS RNAi - Technologies, Markets and Companies Personalized Medicine - Scientific and Commercial Aspects Cytogenetics - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis   GlobalData, Nov 2011, Pages: 19 Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis Summary Myriad Genetics, Inc. (Myriad) is a research focused biotechnology company engaged in the development and commercialization Genetic Testing - Global Strategic Business Report   Global Industry Analysts, Inc., Jan 2011, Pages: 354 Myriad Genetics, Inc. Nanogen, Inc. B.Market Analytics Table 10: US Recent Past, Current & Future Analysis for Genetic Testing by Segment-Pharmacogenomic Testing, Prenatal and Newborn Genetic Myriad RBM, Inc. - Product Pipeline Analysis   GlobalData, Nov 2011, Pages: 19 Myriad RBM, Inc. - Product Pipeline Analysis Summary Myriad RBM, Inc. (RBM), formerly Rules-Based Medicine, Inc., is a healthcare service provider company engaged in providing comprehensive Myriad Genetics Inc   Wright Investors' Service, Feb 2012, Pages: 42 , examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Myriad Genetics Inc. There is a textual review of the financial results of Myriad Genetics Inc Interleukin Genetics, Inc. (ILIU) - Product Pipeline Analysis   GlobalData, Sep 2011, Pages: 21 Data Contact Us Disclaimer Third Wave Technologies, Inc. Allegro Diagnostics, Inc. Clarient, Inc. Satoris, Inc. NBTY, Inc. Myriad Genetics, Inc. Interleukin Genetics, Inc. (ILIU) - Product Pipeline Analysis Companion Diagnostics - Global Strategic Business Report   Global Industry Analysts, Inc., Sep 2011, Pages: 794 Mérieux, Clarient Inc., LabCorp, Merck & Co. Inc., Myriad Genetics, Inc., Power3 Medical Products, Inc., QIAGEN NV, Roche Diagnostics Corp., and Theranostics Health. Market data and analytics are derived from primary Myrexis, Inc. - Product Pipeline Review - H2 2011   Global Markets Direct, Nov 2011, Pages: 65 Product Description Mechanism of Action R&D Progress Vivecon Product Description Mechanism of Action R&D Progress Myrexis, Inc. – Pipeline Analysis Myrexis, Inc. – Pipeline Products Global Molecular Diagnostics Market & Future Forecast 2010-2014   Renub Research, July 2011, Pages: 92 , Gen-Probe, Becton Dickinson and Company, bioMérieux, Myriad Genetics, Inc., Celera Corporation. Data Sources Information and data in this report has been collected from various printable and non DNA Probes-Based Diagnostics - Global Strategic Business Report   Global Industry Analysts, Inc., Jan 2011, Pages: 448 Technology, Inc (USA) - Idexx Laboratories, Inc (USA) - Immunovision, Inc (USA) - Incyte Corporation (USA) - Innogenetics NV (Belgium) - Myriad Genetics, Inc (USA) - Nuvelo, Inc (USA) - Peninsula Nucleic Acid Testing - Global Strategic Business Report   Global Industry Analysts, Inc., June 2010, Pages: 377 ., Cepheid, Inc., Genomic Health, Inc., Gen-Probe Inc., Genzyme Corp., Genzyme Genetics, Myriad Genetics, Inc., Novartis AG, QIAGEN NV, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., and Third Wave The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine   Business Insights, June 2010, Pages: 191 Diagnostics Inc Company description Myriad Genetics Inc Company description Nanosphere Inc Company description Norgen Biotek Company description Novartis International AG Company description Onco Global Cancer Biomarkers Market (2010 - 2015)   Markets and Markets, May 2010, Pages: 193 , Inc 9.26 Laboratory Corp. Of America Holdings 9.27 Morphotek, Inc 9.28 Myriad Genetics, Inc 9.29 Northwest Biotherapeutics Inc 9.30 Ocimum Biosolutions Ltd 9.31 Oncothyreon, Inc 9.32 Polymedco The Top 70 Molecular Diagnostics Manufacturing Companies In North America   Research Facts Ltd, March 2009, Pages: 142 of the major players in this industry like Gen-Probe Incorporated, Myriad Genetics, Inc. and Promega Corporation etc. but this report looks at all 70 of the top companies in North America. Report data field Biomarin Pharmaceutical Inc   Wright Investors' Service, Feb 2012, Pages: 43 Pharmaceutical Inc versus United Therapeutics Corporation, Alexion Pharmaceuticals, Inc. and Myriad Genetics Inc. The comparative analysis of these companies compares Sales (sales, sales growth and sales per Sci-fi to Sci-fact - Market Opportunities for Point of Care DNA Testing Devices   HBS Consulting, Feb 2002, Pages: 123 .8 Careside 87 9.9 Cepheid 88 9.10 Clinical Micro Sensors Inc. 90 9.11 Dade Behring 91 9.12 DiGene Corporation 92 9.13 Hyseq Inc. 93 9.14 Millennium Pharmaceuticals 94 9.15 Myriad Genetics Inc. 96 9.16 Nanogen The Top 100 Molecular Diagnostics Manufacturing Companies Worldwide   Research Facts Ltd, March 2009 Biosystems Ltd. Monogram Biosciences, Inc. Myconostica Ltd. Myriad Genetics, Inc. Nanogen Nanosphere, Inc. NorDiag ASA Novartis Vaccines & Diagnostics, Inc. Nuvera Biosciences OncoMethylome Sciences, Inc Biomarkers and Tests for Pharma/ Biotech R&D – Companies Products and WW Market, 2006-2011   Takeda Pacific, June 2007, Pages: 130 Corporation Luminex Corporation Myriad Genetics, Inc. Nanogen, Inc. Nanosphere, Inc. NimbleGen Systems, Inc. Nymox Pharmaceutical Corporation Orion Genomics LLC Qiagen NV Roche Molecular Diagnostics Sequenom Cancer Diagnostic Testing World Markets   TriMark Publications, July 2011, Pages: 267 .45 Molecular Devices (formerly Arcturus Bioscience, Inc.) 6.46 Myriad Genetics, Inc. 6.47 Northwest Biotherapeutics, Inc. 6.48 ARCA Biopharma 6.49 Oncotech, Inc. 6.50 Oncothyreon, Inc. (formerly Biomira) 6 Bioinformatics - Global Strategic Business Report   Global Industry Analysts, Inc., Jan 2011, Pages: 789 ) -Molecular Ware, Inc (USA) -Molmine AS (Norway) -Molsoft LLC (USA) -Monogram Biosciences, Inc (USA) -MWG Biotech AG (Germany) -Myriad Genetics, Inc (USA) -National Center For Genome Resources (USA) -Net Biomarkers: Discovery Techniques and Applications – A Global Market Overview   Industry Experts, Sep 2010, Pages: 230 Geron Corporation HistoRx, Inc. Life Technologies Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Millipore Corporation Monogram Biosciences, Inc. Myriad Genetics, Inc OSI Pharmaceuticals Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network